Reuters article cites pioneering work of Knoxville-based Provectus
The pioneering work of Knoxville-based Provectus Biopharmaceuticals Inc. employing Rose Bengal has garnered international media recognition in an article published by Reuters. Among other developments, the article cites “a study of 80 people with advanced melanoma (where) half of the patients who had all of their lesions injected appeared cancer free after an average of two months. A year later, 11 percent continued to show no signs of cancer, according to a report published the Annals of Surgical Oncology.”
